跳至主要内容
临床试验/IRCT2016052828127N1
IRCT2016052828127N1已完成2 期

Study of Evaluation of the therapeutic effects of Hab Shabyar on Intraocular pressure in patients with open-angle glaucoma: A double-blind clinical trial

Vice Chancellor for Research (VCR) of Tabriz University of Medical Sciences0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20 years 至 70 years(—)
性别
All

入选标准

  • age between 20-70 years; patients with open-angle glaucoma with IOP 11-21 mm Hg; patients with Informed consent.
  • Exclusion criteria: patients that who have angle-closure glaucoma; Crohn's and Colitis Disease; hemorrhoids; use of systemic drugs to interfere with the IOP and pregnant women.

排除标准

  • 未提供

研究者

发起方
Vice Chancellor for Research (VCR) of Tabriz University of Medical Sciences

相似试验